SIK2, GST-tag Recombinant

Catalog #
40264
$410 *
Size: 10 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Synonyms
SNF1LK2, QIK, KIAA0781, LOH11CR1I, DKFZp434K1115
Product Info
Storage and Usage
Citations
Species
Human
Construct
SIK2 (GST-1-926(end))
Host Species/Expression System
Sf9 insect cells
Purity

≥70%

Format
Aqueous buffer solution
Formulation

50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, 25% glycerol.

MW
150 kDa
Amino Acids
1-926(end)
Glycosylation
This protein runs at a higher M.W. by SDS-PAGE due to glycosylation.
Specific Activity

112 pmol/min/µg

Genbank #
NM_015191
UniProt #
DQ9H0K1
Tag(s)
N-terminal GST-tag
Background

SIK2 is a serine/threonine protein kinase that contains an N-terminal kinase domain, a central domain with ubiquitin-associate motif, and a C-terminal PKA phosphorylation site. SIK2 can phosphorylate IRS1 and overexpression of QIK in adipocyte elevates the phosphorylation of IRS1 (1). The SIK2-mediated phosphorylation of IRS1 may modulate the efficiency of insulin signal transduction and could be responsible for insulin resistance associated with diabetes (1). Insulin disrupts TORC2 activity by induction of SIK2 which then stimulates the phosphorylation and cytoplasmic translocation of TORC2. Phosphorylated TORC2 is subsequently degraded by the 26S proteasome (2).

References
1. Horike N, et al: Adipose-specific expression, phosphorylation of ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J. Biol. Chem. 278: 18440-18447, 2003.
2. Dentin R, et al: Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449: 366-369, 2007.